Drugs usually have no natural affinity for the cells, tissues and organs where therapeutic effects are needed, which frequently results in low efficiency and unwanted side effects. This concern is even more profound when using highly potent and cytotoxic anticancer drugs or specific agents, such as enzymes and genetic materials, since their effective and safe action requires precise cellular or even sub-cellular addressing in the target organ. To meet safety, efficiency and specificity requirements, drugs somehow must be targeted to the sites of their expected therapeutic action. The idea of the "magic bullet," or drug targeting, proposed by Erlich a century ago, generates great and continuously growing interest in biomedical, industrial and financial circles. This book is focused on the strategies designed to target therapeutic or diagnostic agents to the disease sites. In an attempt to include in this volume the set of chapters reflecting both traditional and emerging areas of drug targeting, we have contacted many leading scientists in the field asking for their contributions. Their responses were most favorable and encouraging. As a result, we have succeeded in assembling a series of outstanding contributions reflecting practically all the key areas of drug targeting. The final structure of this book is as follows.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Section 1: General Principles of Drug Targeting. 1. Strategies and means for drug targeting: an overview; V.P. Torchilin. 2. Biological barriers for drug targeting; V.R. Muzykantov. Section 2: Cardiovascular Targeting. 3. Targeting the pathological myocardium; Ban-An Khaw. 4. Targeting atherosclerotic plaques; Ban-An Khaw. 5. Thrombus targeting of plasminogen activators and anticoagulants; K. Peter, C. Bode. 6. Tissue-specific pharmacodelivery and overcoming key cell barriers in vivo: vascular targeting of calveolae; L.A. Carver, J.E. Schnitzer. 7. Targeting pulmonary endothelium; V.R. Muzykantov. 8. Targeting inflammation; J.R. Lindner, A.L. Klibanov, K. Ley. 9. Intravascular re-targeting of viral vectors; P.N. Reynolds, S.M. Danilov. Section 3: Tumor Targeting. 10. Polymer-drug conjugates: targeting cancer; R. Duncan. 11. Enhanced permeability and retention (EPR) effect: basis for drug targeting to tumor; H. Maeda. 12. Ligand-directed destruction of tumor vascalature; S. Ran, M. Rosenblum, P.E. Thorpe. 13. Tumor necrosis treatment and imaging of solid tumors; A.L. Epstein, L.A. Khawli, Peisheng Hu. 14. Targeted apoptosis: antibodies linked to RNA damaging agents; S.M. Rybak, M. Arndt, J. Krauss, D.L. Newton, B.K. Vu, Zhongyu Zhu. 15. Immunotoxins and antibody-drug conjugates for cancer treatment; V.S. Goldmacher, W.A. Blättler, J.M. Lambert, R.V.J. Chari. Section 4: Targeting to Brain. 16. Blood-brain barrier transport and drug targeting to the brain; K. Hosoya, S. Ohtsuki, T.Terasaki. 17. LDL-receptor mediated drug targeting to malignant tumors in the brain; R. Sarkar, D.S. Halpern, S.K. Jacobs, D.R. Lu. 18. Targeting brain trauma and stroke; M.A. Petty, Eng H. Lo. 19. Targeting drugs into the central nervous system; L. Prokai. Section 5: Miscellaneous, New Horizons in Targeting. 20. Strategies for targeting infection; J.W. Babich. 21.Anti-HIV immunotoxins; S.H. Pincus, Huang Fa, R. Wilkinson. 22. Ligand-mediated gastrointestinal targeting; J. Woodley. 23. Transmembrane targeting of DNA with membrane active peptides; S. Boeckle, E. Wagner, M. Ogris. 24. Polymersomes: a new platform for drug targeting; D.E. Discher, P. Photos, F. Ahmed, R. Parthasrathy. 25. Targeting mitochondria; V. Weissig, D. D'Souza, V.P. Torchilin. Index.
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
EUR 22,98 per la spedizione da Regno Unito a Italia
Destinazione, tempi e costiEUR 9,70 per la spedizione da Germania a Italia
Destinazione, tempi e costiDa: The Book Exchange, Macclesfield, CHESH, Regno Unito
Hardcover. Condizione: Near Fine. 1402072325. Hardcover, from closed pharmaceutical company library. Lending record shows this book has never been borrowed. 506 pages, index, illustrated with charts, tables and diagrams. Includes general principles of drug targeting, targeting in the cardiovascular system, tumor targeting, brain targeting, miscellaneous targeting and novel approaches. In a course-like fashion: from general and simple to specific and complex material. For pharmacologists and drug discovery researchers, along with advanced level graduate students. The book focuses on ligand-mediated drug targeting strategies, with additional chapters on general aspects of drug delivery that are of paramount importance in drug targeting (biological barriers, stealth technologies). Included are topics on targeting of genetic materials important in the biomedical context of the ligand-mediated targeting. Contents as new, clean, tight and bright. Book. Codice articolo 027082
Quantità: 1 disponibili
Da: Ammareal, Morangis, Francia
Hardcover. Condizione: Très bon. Ancien livre de bibliothèque avec équipements. Edition 2003. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Very good. Former library book. Edition 2003. Ammareal gives back up to 15% of this item's net price to charity organizations. Codice articolo F-979-743
Quantità: 1 disponibili
Da: ThriftBooks-Dallas, Dallas, TX, U.S.A.
Hardcover. Condizione: Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less 2.02. Codice articolo G1402072325I3N00
Quantità: 1 disponibili
Da: moluna, Greven, Germania
Gebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Drugs usually have no natural affinity for the cells, tissues and organs where therapeutic effects are needed, which frequently results in low efficiency and unwanted side effects. This concern is even more profound when using highly potent and cytotoxic an. Codice articolo 4094933
Quantità: Più di 20 disponibili
Da: Ria Christie Collections, Uxbridge, Regno Unito
Condizione: New. In. Codice articolo ria9781402072321_new
Quantità: Più di 20 disponibili
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: New. Codice articolo 1693376-n
Quantità: 15 disponibili
Da: Best Price, Torrance, CA, U.S.A.
Condizione: New. SUPER FAST SHIPPING. Codice articolo 9781402072321
Quantità: 2 disponibili
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
Buch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Drugs usually have no natural affinity for the cells, tissues and organs where therapeutic effects are needed, which frequently results in low efficiency and unwanted side effects. This concern is even more profound when using highly potent and cytotoxic anticancer drugs or specific agents, such as enzymes and genetic materials, since their effective and safe action requires precise cellular or even sub-cellular addressing in the target organ. To meet safety, efficiency and specificity requirements, drugs somehow must be targeted to the sites of their expected therapeutic action. The idea of the 'magic bullet,' or drug targeting, proposed by Erlich a century ago, generates great and continuously growing interest in biomedical, industrial and financial circles. This book is focused on the strategies designed to target therapeutic or diagnostic agents to the disease sites. In an attempt to include in this volume the set of chapters reflecting both traditional and emerging areas of drug targeting, we have contacted many leading scientists in the field asking for their contributions. Their responses were most favorable and encouraging. As a result, we have succeeded in assembling a series of outstanding contributions reflecting practically all the key areas of drug targeting. The final structure of this book is as follows.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 532 pp. Englisch. Codice articolo 9781402072321
Quantità: 1 disponibili
Da: AHA-BUCH GmbH, Einbeck, Germania
Buch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Drugs usually have no natural affinity for the cells, tissues and organs where therapeutic effects are needed, which frequently results in low efficiency and unwanted side effects. This concern is even more profound when using highly potent and cytotoxic anticancer drugs or specific agents, such as enzymes and genetic materials, since their effective and safe action requires precise cellular or even sub-cellular addressing in the target organ. To meet safety, efficiency and specificity requirements, drugs somehow must be targeted to the sites of their expected therapeutic action. The idea of the 'magic bullet,' or drug targeting, proposed by Erlich a century ago, generates great and continuously growing interest in biomedical, industrial and financial circles. This book is focused on the strategies designed to target therapeutic or diagnostic agents to the disease sites. In an attempt to include in this volume the set of chapters reflecting both traditional and emerging areas of drug targeting, we have contacted many leading scientists in the field asking for their contributions. Their responses were most favorable and encouraging. As a result, we have succeeded in assembling a series of outstanding contributions reflecting practically all the key areas of drug targeting. The final structure of this book is as follows. Codice articolo 9781402072321
Quantità: 1 disponibili
Da: GreatBookPrices, Columbia, MD, U.S.A.
Condizione: As New. Unread book in perfect condition. Codice articolo 1693376
Quantità: 15 disponibili